Cagnin Silvia, Martini Andrea, Donato Daniele, Angeli Paolo, Pontisso Patrizia
Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), Padova Teaching Hospital, Padua, Italy.
Medical Head Office, Padova Teaching Hospital, Padua, Italy.
Intern Emerg Med. 2024 Apr;19(3):641-647. doi: 10.1007/s11739-023-03507-1. Epub 2024 Jan 16.
Chronic liver disease (CLD) is a leading global cause of mortality, morbidity, and healthcare resource utilization. However, the burden of CLD is underestimated because the course of the disease is often asymptomatic until clinical decompensation and the development of life-threatening complications. In this study, we assessed the use of available blood tests from electronic medical records for identifying individuals with undiagnosed CLD in the general population. We analyzed a total of 202,529 blood tests obtained from 99,848 adults recorded in the Electronic Health Records of the Padova Teaching Hospital. Transaminases levels > 1.5 times the normal value indicated occult CLD, while platelet counts < 120,000/μL identified occult cirrhosis. We characterized patients using Italian Medical Exemptions (IME), excluding oncologic cases. Overt and occult cirrhosis prevalence was 1% and 4.18%, respectively, while overt and occult CLD affected 2.85% and 4.61% of the population. The epidemiology of patients with overt and occult cirrhosis was similar but significantly different from that of the controls. Among subjects aged 60-70 years, working disability was twofold higher in those with occult cirrhosis compared to those with overt cirrhosis. Occult CLD and cirrhosis had higher prevalence rates than diagnosed cases in the general population. Electronic medical record data may serve as a valuable tool for CLD identification, potentially reducing cirrhosis development and clinical decompensation. This, in turn, may lead to a decrease in the economic impact on the healthcare system.
慢性肝病(CLD)是全球死亡率、发病率和医疗资源利用的主要原因。然而,CLD的负担被低估了,因为在临床失代偿和危及生命的并发症发生之前,该疾病的病程通常没有症状。在本研究中,我们评估了利用电子病历中的现有血液检测来识别普通人群中未诊断出的CLD个体。我们分析了从帕多瓦教学医院电子健康记录中记录的99848名成年人那里获得的总共202529份血液检测。转氨酶水平>正常价值的1.5倍表明存在隐匿性CLD,而血小板计数<120,000/μL则可识别隐匿性肝硬化。我们使用意大利医疗豁免(IME)对患者进行特征描述,排除肿瘤病例。显性和隐匿性肝硬化的患病率分别为1%和4.18%,而显性和隐匿性CLD分别影响了2.85%和4.61%的人群。显性和隐匿性肝硬化患者的流行病学情况相似,但与对照组有显著差异。在60 - 70岁的人群中,隐匿性肝硬化患者的工作残疾率是显性肝硬化患者的两倍。在普通人群中,隐匿性CLD和肝硬化的患病率高于已诊断病例。电子病历数据可能是识别CLD的有价值工具,有可能减少肝硬化的发展和临床失代偿。反过来,这可能会降低对医疗系统的经济影响。